Canada, November 14, 2025, Health Canada has just proposed a major update to the Medical Devices Regulations (MDR) that could make it easier and less costly for medical device companies to do business in Canada. The proposed changes, published in Canada Gazette, Part I (Vol. 159, No. 45), are now open for public consultation until January 17, 2026, and they’re already making waves across the medical technology sector.
CANADA GAZETTE: WHAT’S NEW IN THE AMENDMENTS TO THE MEDICAL DEVICES REGULATIONS?
Effective 180 days after registration (target mid‑2026), Health Canada proposes the following key changes to the Medical Devices Regulations (MDR) regarding establishment licences (MDELs):
- Foreign distributors will no longer be required to hold an MDEL when their Canadian importer is already licensed.
- MDEL applicants and holders must provide detailed supplier information (supplier name, address, device risk class) at the time of application and annually.
- All manufacturers, importers and distributors must have documented procedures covering distribution records, incident reporting, storage/handling, servicing/installation, corrective actions, and serious‑risk communication.
NEW RULE: FOREIGN DISTRIBUTORS CAN OPERATE WITHOUT AN MDEL
One of the most significant changes is the removal of the requirement for foreign distributors to hold a Medical Device Establishment Licence (MDEL) as long as their Canadian importer already has one.
Until now, both the importer and the foreign distributor were required to hold MDELs, a system many in the industry viewed as redundant and burdensome. Industry voices have long argued that this duplication doesn’t exist in other major markets like the U.S., EU, or Australia.
With this change, foreign distributors can now sell into Canada without their own MDEL—if their importer is licensed. For manufacturers, this not only reduces costs and administrative effort, but also opens the door to more flexible supply chain partnerships.
WHY THIS MATTERS FOR MANUFACTURERS
- Market access improvement: For non‑Canadian manufacturers working with Canadian importers, the removal of the foreign‑distributor MDEL requirement simplifies entry to the Canadian market.
- Supply‑chain transparency: Manufacturers will need to ensure their downstream partners (importers/distributors) have accurate records of suppliers and device risk classes to support Canadian importer compliance.
- Documented system alignment: If you already comply with ISO 13485 (especially Class II–IV), the documented‑procedure requirement largely aligns with your existing QMS. For Class I device manufacturers or new entrants, now is the time to formalise procedures.
- Regulatory readiness: The changes support better traceability and oversight by Health Canada; manufacturers should review contracts, supplier lists and SOPs now to avoid last‑minute rush.
INDUSTRY ADVANTAGE: COSTS DOWN, BENEFITS UP
From a cost standpoint, the government estimates:
- $1.68 million in total costs over 10 years for industry (mainly admin time)
- $163,000 in added administrative cost for Health Canada
But the benefits are much bigger:
- $2.3 million in potential savings for foreign distributors who no longer need an MDEL
- Clearer compliance expectations for everyone
- Faster, more targeted enforcement when safety issues arise
For many in the industry, this is a long-awaited modernization that aligns Canada’s framework more closely with international best practices.
TRANSITION TIMELINE AND STAKEHOLDER ACTIONS
These changes are expected to come into effect six months after registration, likely by mid-2026. Health Canada has committed to a risk-based enforcement model, and will be updating its guidance documents and forms accordingly. Manufacturers, importers, and distributors are encouraged to review the proposed regulations and submit feedback during the consultation period.
FINAL SUMMARY
If you’re a medical device manufacturer, especially one operating outside – Canada this proposed regulatory change is a breath of fresh air.
For years, manufacturers and distributors have had to juggle dual licensing requirements, navigate unclear documentation expectations, and face administrative slowdowns just to keep products flowing into Canada. Now, with Health Canada stepping in to simplify the system, the path to the Canadian market is starting to look a lot more inviting.
By removing the need for foreign distributors to hold an MDEL when working with a licensed Canadian importer, the government is saying: “Let’s make this easier without compromising safety.” That’s a big deal especially for smaller or emerging manufacturers looking to grow in North America.